The following sections of the Standards of Medical Care in Diabetes—2021 have been updated to include the latest evidence-based recommendations from the American Diabetes Association: Classification and Diagnosis of Diabetes, Cardiovascular Disease and Risk Management, and Microvascular Complications and Foot Care. To access the updates, please visit

This self-paced, online program delivers easily accessible continuing education to meet the needs of busy primary care providers. This bundle, offering up to 10 continuing education credits or American Board of Internal Medicine Maintenance of Certification points, offers nine modules as well as exclusive, “Ask the Expert” live events, an online learning collaborative to share best practices and network with colleagues, and a 1-year American Diabetes Association professional membership. For more information, please visit

Diabetic kidney disease remains an important clinical problem with substantial medical comorbidity despite many recent medical advances. As more therapeutic opportunities become established, an improved understanding of the mechanisms underlying the progression of diabetic vascular disease and target organ damage is needed so that newer and traditional therapeutic options can be used together most efficiently to improve clinical outcomes. This compendium, supported by unrestricted education grants from AstraZeneca and Bayer, provides an opportunity to gauge progress in the efforts underway to improve longer-term outcomes for patients who have diabetes and chronic kidney disease. Access the PDF for free at compendium_fin_2_web.pdf.

Filled with practical tips, this series of short videos showcases leading experts sharing pragmatic strategies for overcoming therapeutic inertia in your practice today. ADA encourages viewers to try these approaches out for themselves and to share them with other clinicians within their networks. The series is hosted by Dr. Neil Skolnik and features guests such as ADA's Chief Scientific and Medical Officer Dr. Robert Gabbay; Dr. Kamlesh Khunti, a researcher from University of Leicester, U.K.; and others. To view the full series, visit

In a series of short videos now available on the Clinical Diabetes website, Drs. Vivian Fonseca, Minisha Sood, and Rodolfo Galindo discuss the pathophysiological changes that occur during the progression of type 2 diabetes, with a particular focus on the key role of declining β-cell function, as well as the clinical characteristics—long duration of type 2 diabetes and A1C ≥9%—that are indicative of diminishing β-cell function. An executive summary and videos of the full panel can be found at

“Diabetes and COVID-19” is an online collection of articles on the Diabetes Care website featuring the latest studies, clinical observations, and commentaries on COVID-19 with specific relation to patients with diabetes. Topics include management of diabetes and its complications during the pandemic, blood glucose control and remote glucose monitoring, and outcomes in patients with hyperglycemia, cardiovascular risk, and obesity. This web page is updated regularly as relevant Diabetes Care articles are published online ahead of print. To access the collection, visit

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at